UREA

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
60.0 -1.0 2 1 69.0 0 0.0
CAS
57136
UNII
8W8T17847W
SYNONYMS
ZINC ID(s)
Availability
Present in 83 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT02251392 2015-07-01 Evaluation of Therapeutic Efficacy in Use of Chamomilla Gel, Chamomilla Infuse and Urea in Radiodermatitis Phase 3 Not Yet Recruiting
NCT02247830 2015-04-01 Management Radiodermatitis in Patients With Breast or Head and Neck Cancer Phase 3 Enrolling By Invitation
NCT02249884 2014-02-01 Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis Phase 2 Recruiting
NCT02017873 2013-12-01 Longevity and Effectiveness of Bleaching in Healthy and Smokers Patients Phase 4 Completed
NCT01909141 2013-08-01 Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS Phase 0 Completed
NCT01934829 2009-07-01 Urea Cream Treatment Sorafenib-Associated HSFR in HCC Phase 2 Completed
NCT00667589 2008-06-01 Sorafenib-induced Hand- Foot Skin Reaction Treatment Phase 2 Terminated
NCT01347775 2007-12-01 Inspiratory Muscle Training in Patients With End Stage Renal Failure Phase 4 Active, Not Recruiting
NCT00576550 2007-10-01 A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema Phase 4 Completed
NCT00196443 2005-06-01 The Influence of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Disease Phase 2/Phase 3 Completed
NCT00576238 2004-01-01 Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser Phase 3 Completed
NCT00197457 2001-06-01 Pepsinogens as the Early Marker of H. Pylori Eradication Phase 2 Completed

(Browse) Purchasable Analogs in ZINC

Regulatory Status of Urea

Gras - Generally recognized as safe.

Dosages

Route Formulation Per Unit Dose
Intramuscular Injection
Oral Tablet, Coated 0.02MG
Oral Tablet, Sustained Action 0.01MG
Topical Patch
Vaginal Emulsion, Cream 0.64%
Vaginal Tablet 50MG

More Information

Usage Over Time

Comments